DeVilbiss News

SOMERSET, PA – April 10, 2014 – DeVilbiss Healthcare was recently awarded a patent* for its innovative SmartCode® Remote Therapy Monitoring system. The development of SmartCode technology revolutionized the way in which patients can remotely report CPAP therapy usage and efficacy data to the health provider. With this patent, DeVilbiss is now protected from other imitation codes on the market.

SOMERSET, PA – January 21, 2014– DeVilbiss Healthcare has added a new nasal mask to its line of CPAP interfaces. The EasyFit Lite Nasal Mask provides a number of the premium features found on DeVilbiss’ existing EasyFit Nasal Mask in a more economical package. Built for the perfect fit, the mask’s cushion was created by utilizing computer analyses of facial characteristics from 50,000 individuals globally.

SOMERSET, PA – December 2, 2013 – Built upon a legacy of reliable, field-proven concentrator models and re-introduced today, the DeVilbiss 5 Liter Oxygen Concentrator was updated with enhanced quality, durability, performance and simplicity in mind. Now made in the USA*, concentrator production has moved to DeVilbiss headquarters in Somerset, Pa.

 

SOMERSET, PA – November 15, 2013 – DeVilbiss Healthcare re-introduced today the PulmoNeb LT Compressor Nebulizer System, now made in the USA of US and imported parts.

If you meet certain requirements, you could take part in a research study focused on improving the accuracy of CPAP treatment and better meeting each person’s individualized treatment requirements automatically.

 

To qualify, you must:

  • Have a diagnosis of moderate to severe obstructive sleep apnea, or central/complex sleep apnea
  • Be on stable CPAP or APAP therapy with compliant use averaging four or more hours nightly, for at least the past three months
  • Be 21 to 75 years or age

 

Participation Overview

This study includes two visits to the NeuroCare Center for Sleep in Newton, MA, a suburb of Boston:

  • Visit 1: screening.
  • Visit 2: overnight PSG in sleep lab.

 

Compensation

  • $50 for screening; $200 participation. Total $250 to qualified participants

 

If interested, please complete the information to the right and “submit.” We will then contact you.

 

» Continue to US website

DeVilbiss Healthcare

Thank you for visiting DeVilbiss Healthcare. Please note that all information contained on this website including, but not limited to, warranties, product specifications and model availability is specific to products offered to North American customers only. To learn more about DeVilbiss products that are sold internationally, please visit one of these websites:

DeVilbiss Healthcare does not sell directly to consumers. Please go to http://www.devilbisshealthcare.com/find-a-provider to locate a DeVilbiss provider near you.